These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 31220415)

  • 21. Cytoplasmic polyadenylation by TENT5A is required for proper bone formation.
    Gewartowska O; Aranaz-Novaliches G; Krawczyk PS; Mroczek S; Kusio-Kobiałka M; Tarkowski B; Spoutil F; Benada O; Kofroňová O; Szwedziak P; Cysewski D; Gruchota J; Szpila M; Chlebowski A; Sedlacek R; Prochazka J; Dziembowski A
    Cell Rep; 2021 Apr; 35(3):109015. PubMed ID: 33882302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta.
    Christiansen HE; Schwarze U; Pyott SM; AlSwaid A; Al Balwi M; Alrasheed S; Pepin MG; Weis MA; Eyre DR; Byers PH
    Am J Hum Genet; 2010 Mar; 86(3):389-98. PubMed ID: 20188343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone collagen: new clues to its mineralization mechanism from recessive osteogenesis imperfecta.
    Eyre DR; Weis MA
    Calcif Tissue Int; 2013 Oct; 93(4):338-47. PubMed ID: 23508630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteogenesis imperfecta and therapeutics.
    Morello R
    Matrix Biol; 2018 Oct; 71-72():294-312. PubMed ID: 29540309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of WNT1 mutant variant (WNT1
    Zhang B; Li R; Wang W; Zhou X; Luo B; Zhu Z; Zhang X; Ding A
    Ann Hum Genet; 2020 Nov; 84(6):447-455. PubMed ID: 32757296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of TRIC-B from type XIV Osteogenesis Imperfecta osteoblasts alters cell adhesion and mitochondrial function - A multi-omics study.
    Jovanovic M; Mitra A; Besio R; Contento BM; Wong KW; Derkyi A; To M; Forlino A; Dale RK; Marini JC
    Matrix Biol; 2023 Aug; 121():127-148. PubMed ID: 37348683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crispr-Cas9 engineered osteogenesis imperfecta type V leads to severe skeletal deformities and perinatal lethality in mice.
    Rauch F; Geng Y; Lamplugh L; Hekmatnejad B; Gaumond MH; Penney J; Yamanaka Y; Moffatt P
    Bone; 2018 Feb; 107():131-142. PubMed ID: 29174564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on the Genetics of Osteogenesis Imperfecta.
    Jovanovic M; Marini JC
    Calcif Tissue Int; 2024 Dec; 115(6):891-914. PubMed ID: 39127989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mutations of noncollagen genes in osteogenesis imperfecta--implications of the gene products in collagen biosynthesis and pathogenesis of disease].
    Galicka A
    Postepy Hig Med Dosw (Online); 2012 Jun; 66():359-71. PubMed ID: 22706122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MBTPS2 mutations cause defective regulated intramembrane proteolysis in X-linked osteogenesis imperfecta.
    Lindert U; Cabral WA; Ausavarat S; Tongkobpetch S; Ludin K; Barnes AM; Yeetong P; Weis M; Krabichler B; Srichomthong C; Makareeva EN; Janecke AR; Leikin S; Röthlisberger B; Rohrbach M; Kennerknecht I; Eyre DR; Suphapeetiporn K; Giunta C; Marini JC; Shotelersuk V
    Nat Commun; 2016 Jul; 7():11920. PubMed ID: 27380894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel splicing mutation in FKBP10 causing osteogenesis imperfecta with a possible mineralization defect.
    Venturi G; Monti E; Dalle Carbonare L; Corradi M; Gandini A; Valenti MT; Boner A; Antoniazzi F
    Bone; 2012 Jan; 50(1):343-9. PubMed ID: 22061863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfecta.
    Lisse TS; Thiele F; Fuchs H; Hans W; Przemeck GK; Abe K; Rathkolb B; Quintanilla-Martinez L; Hoelzlwimmer G; Helfrich M; Wolf E; Ralston SH; Hrabé de Angelis M
    PLoS Genet; 2008 Feb; 4(2):e7. PubMed ID: 18248096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel variant in Sp7/Osx associated with recessive osteogenesis imperfecta with bone fragility and hearing impairment.
    Fiscaletti M; Biggin A; Bennetts B; Wong K; Briody J; Pacey V; Birman C; Munns CF
    Bone; 2018 May; 110():66-75. PubMed ID: 29382611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Makings of a brittle bone: Unexpected lessons from a low protein diet study of a mouse OI model.
    Mertz EL; Makareeva E; Mirigian LS; Koon KY; Perosky JE; Kozloff KM; Leikin S
    Matrix Biol; 2016; 52-54():29-42. PubMed ID: 27039252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 4-PBA Treatment Improves Bone Phenotypes in the Aga2 Mouse Model of Osteogenesis Imperfecta.
    Duran I; Zieba J; Csukasi F; Martin JH; Wachtell D; Barad M; Dawson B; Fafilek B; Jacobsen CM; Ambrose CG; Cohn DH; Krejci P; Lee BH; Krakow D
    J Bone Miner Res; 2022 Apr; 37(4):675-686. PubMed ID: 34997935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defect.
    Marom R; Song IW; Busse EC; Washington ME; Berrier AS; Rossi VC; Ortinau L; Jeong Y; Jiang MM; Dawson BC; Adeyeye M; Leynes C; Lietman CD; Stroup BM; Batkovskyte D; Jain M; Chen Y; Cela R; Castellon A; Tran AA; Lorenzo I; Meyers DN; Huang S; Turner A; Shenava V; Wallace M; Orwoll E; Park D; Ambrose CG; Nagamani SC; Heaney JD; Lee BH
    J Clin Invest; 2024 Jun; 134(15):. PubMed ID: 38885336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy.
    Gioia R; Panaroni C; Besio R; Palladini G; Merlini G; Giansanti V; Scovassi IA; Villani S; Villa I; Villa A; Vezzoni P; Tenni R; Rossi A; Marini JC; Forlino A
    Stem Cells; 2012 Jul; 30(7):1465-76. PubMed ID: 22511244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered cytoskeletal organization characterized lethal but not surviving Brtl+/- mice: insight on phenotypic variability in osteogenesis imperfecta.
    Bianchi L; Gagliardi A; Maruelli S; Besio R; Landi C; Gioia R; Kozloff KM; Khoury BM; Coucke PJ; Symoens S; Marini JC; Rossi A; Bini L; Forlino A
    Hum Mol Genet; 2015 Nov; 24(21):6118-33. PubMed ID: 26264579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenic mechanisms of osteogenesis imperfecta, evidence for classification.
    Yu H; Li C; Wu H; Xia W; Wang Y; Zhao J; Xu C
    Orphanet J Rare Dis; 2023 Aug; 18(1):234. PubMed ID: 37559063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteogenesis imperfecta: new genes reveal novel mechanisms in bone dysplasia.
    Kang H; Aryal A C S; Marini JC
    Transl Res; 2017 Mar; 181():27-48. PubMed ID: 27914223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.